Literature DB >> 964549

In vitro transformation of newborn hamster cells induced by sodium nitrite.

H Tsuda, N Inui, S Takayama.   

Abstract

The in vitro carcinogenicity of sodium nitrite was examined. Addition of a high concentration of sodium nitrite (50 mM or 100 mM) to mass cultures of newborn hamster cells for 24 hr resulted in morphological transformation of the cells. The shortest time required for morphological transformation after this treatment was 21 days. Two of 5 transformed cultures produced progressively growing tumors when injected into young adult hamsters. These tumors were diagnosed as fibrosarcomas. In two control cultures of the same experimental groups, transformed cells appeared 10 weeks or more later than those in treated cultures. The chromosomes were analysed at several stages of transformation. In the early stages of transformation, chromosome number varied widely from near diploid to tetraploid, but later they became near diploid. Morphological alteration caused by sodium nitrite was also seen in a short-term assay, in which hamster embryonic cells (1 x 10(4) cells/60 mm dish) were treated and morphology was observed 8 days after the treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 964549

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  3 in total

Review 1.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

2.  Identification of tumor promoters by their inhibitory effect on intercellular transfer of lucifer yellow.

Authors:  I V Budunova; L A Mittelman; G A Belitsky
Journal:  Cell Biol Toxicol       Date:  1989-01       Impact factor: 6.691

3.  Induction of 8-azaguanine-resistant mutation and neoplastic transformation of hamster embryonic cells by coadministration of sodium nitrite and aminopyrine.

Authors:  N Inui; Y Nishi; M M Hasegawa; M Taketomi; M Yamamoto; A Tanimura
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.